Literature DB >> 34330221

Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes.

Dyah Samti Mayasari1, Nahar Taufiq2,3, Hariadi Hariawan2,3.   

Abstract

BACKGROUND: Previous studies proposed that chronic inflammation in diabetes has a role in abnormal collagen production and elastin degradation, which promotes arterial stiffness. Monocyte-to-High Density Lipoprotein cholesterol ratio (MHR) is a simple measurement associated with inflammation and oxidative stress. However, little is known about the relationship of MHR with arterial stiffness. This study aimed to determine the association of MHR with arterial stiffness in patients with diabetes.
METHODS: A total of 81 patients with type 2 diabetes mellitus were enrolled in a cross-sectional study. Arterial stiffness factor in this study was Cardio Ankle Vascular Index (CAVI). We analyzed complete blood count and lipid profile in all participants, then performed statistical analysis to determine the relationship between MHR and CAVI. Receiver operating characteristic (ROC) analysis was used to estimate the cut-off values of MHR to predict CAVI ≥ 9.
RESULTS: Median of MHR in this study was 11.91 with the mean of CAVI was 8.13 ± 0.93. Spearman correlation analysis revealed a significant positive correlation between MHR and CAVI (ρ = 0.239, p = 0.031). Multivariate analysis showed the independent association of MHR to arterial stiffness (β = 0.361, 95% CI 0.023-0.093) and to CAVI ≥ 9 (OR 1.181, 95% CI 1.047-1.332). The cut-off values of MHR for predicting CAVI ≥ 9 were identified as ≥ 13 (OR 3.289, 95% CI 1.036-10.441).
CONCLUSION: MHR is associated with CAVI in patients with diabetes, irrespective of various potential confounders.
© 2021. The Author(s).

Entities:  

Keywords:  Arterial stiffness; Cardio ankle vascular index; Diabetes; Inflammation biomarkers; Monocyte-to-HDL ratio

Year:  2021        PMID: 34330221     DOI: 10.1186/s12872-021-02180-6

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  19 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  A Novel Marker of Impaired Aortic Elasticity in Never Treated Hypertensive Patients: Monocyte/High-Density Lipoprotein Cholesterol Ratio.

Authors:  Kadriye Gayretli Yayla; Uğur Canpolat; Çagri Yayla; Mehmet Kadri Akboğa; Ahmet Akyel; Ahmet Akdi; Gökhan Çiçek; Firat Ozcan; Osman Turak; Sinan Aydoğdu
Journal:  Acta Cardiol Sin       Date:  2017-01       Impact factor: 2.672

Review 3.  Vascular complications of diabetes: mechanisms of injury and protective factors.

Authors:  Christian Rask-Madsen; George L King
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

4.  Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis.

Authors:  Caroline M L Chapman; John P Beilby; Brendan M McQuillan; Peter L Thompson; Joseph Hung
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

5.  Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.

Authors:  Ahmet Karatas; Ercan Turkmen; Emre Erdem; Harun Dugeroglu; Yasemin Kaya
Journal:  Biomark Med       Date:  2018-07-25       Impact factor: 2.851

6.  Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus.

Authors:  Kai-Hang Yiu; Chun-Ting Zhao; Yan Chen; Chung-Wah Siu; Yap-Hang Chan; Kui-Kai Lau; Shasha Liu; Chu-Pak Lau; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2013-06-22       Impact factor: 9.951

7.  Associations between Type 2 Diabetes Mellitus and Arterial Stiffness: A Prospective Analysis Based on the Maine-Syracuse Study.

Authors:  Merrill F Elias; Georgina E Crichton; Peter J Dearborn; Michael A Robbins; Walter P Abhayaratna
Journal:  Pulse (Basel)       Date:  2017-08-26

8.  Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients.

Authors:  Guido Gembillo; Rossella Siligato; Valeria Cernaro; Ersilia Satta; Giovanni Conti; Antonino Salvo; Adolfo Romeo; Vincenzo Calabrese; Giovanna Sposito; Guido Ferlazzo; Domenico Santoro
Journal:  Int Urol Nephrol       Date:  2021-06-09       Impact factor: 2.370

Review 9.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.

Authors:  Francesco Paneni; Joshua A Beckman; Mark A Creager; Francesco Cosentino
Journal:  Eur Heart J       Date:  2013-05-02       Impact factor: 29.983

10.  Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study.

Authors:  Jeong Mi Kim; Sang Soo Kim; In Joo Kim; Jong Ho Kim; Bo Hyun Kim; Mi Kyung Kim; Soon Hee Lee; Chang Won Lee; Min Chul Kim; Jun Hyeob Ahn; Jinmi Kim
Journal:  Cardiovasc Diabetol       Date:  2020-09-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.